OA12464A - Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors. - Google Patents

Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors. Download PDF

Info

Publication number
OA12464A
OA12464A OA1200300253A OA1200300253A OA12464A OA 12464 A OA12464 A OA 12464A OA 1200300253 A OA1200300253 A OA 1200300253A OA 1200300253 A OA1200300253 A OA 1200300253A OA 12464 A OA12464 A OA 12464A
Authority
OA
OAPI
Prior art keywords
alkyl
het1
het2
aryl
amino
Prior art date
Application number
OA1200300253A
Other languages
English (en)
Inventor
Dominique Louis Nest Surleraux
Sandrine Marie Hele Vendeville
Wim Gaston Verschueren
De Marie-Pierre T M M Bethune
Herman Augustinus De Kock
Abdellah Tahri
Montserrat Erra Sola
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of OA12464A publication Critical patent/OA12464A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
OA1200300253A 2001-04-09 2002-04-09 Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors. OA12464A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01201308 2001-04-09
US28770401P 2001-05-02 2001-05-02

Publications (1)

Publication Number Publication Date
OA12464A true OA12464A (en) 2006-05-24

Family

ID=26076876

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200300253A OA12464A (en) 2001-04-09 2002-04-09 Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors.

Country Status (25)

Country Link
US (2) US7244752B2 (ja)
EP (1) EP1397367A2 (ja)
JP (1) JP4417010B2 (ja)
KR (1) KR100872029B1 (ja)
CN (1) CN100491360C (ja)
AP (1) AP1544A (ja)
AR (1) AR035819A1 (ja)
AU (1) AU2002257774B2 (ja)
BG (1) BG66371B1 (ja)
BR (1) BR0208796A (ja)
CA (1) CA2442870C (ja)
CZ (1) CZ303139B6 (ja)
EA (1) EA007383B1 (ja)
EE (1) EE05384B1 (ja)
HR (1) HRP20030905B1 (ja)
HU (1) HUP0303744A3 (ja)
IL (1) IL158092A0 (ja)
MX (1) MXPA03009179A (ja)
NO (1) NO328896B1 (ja)
NZ (1) NZ528954A (ja)
OA (1) OA12464A (ja)
PL (1) PL367084A1 (ja)
SK (1) SK288232B6 (ja)
WO (1) WO2002081478A2 (ja)
ZA (1) ZA200307683B (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
OA12464A (en) * 2001-04-09 2006-05-24 Tibotec Pharm Ltd Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors.
DK1387842T3 (da) * 2001-05-11 2009-08-10 Tibotec Pharm Ltd Bredspektrede 2-amino-benzoxazolsulfonamid-HIV-protease-inhibitorer
EP1472536A4 (en) 2002-01-07 2007-02-14 Sequoia Pharmaceuticals VERSATILE INHIBITORS
US7285566B2 (en) * 2002-01-07 2007-10-23 Erickson John W Resistance-repellent retroviral protease inhibitors
US7157489B2 (en) 2002-03-12 2007-01-02 The Board Of Trustees Of The University Of Illinois HIV protease inhibitors
JP4674084B2 (ja) * 2002-05-17 2011-04-20 テイボテク・フアーマシユーチカルズ・リミテツド 広域スペクトルの置換ベンズイソキサゾールスルホンアミドhivプロテアーゼ阻害剤
CN1953964A (zh) * 2004-03-11 2007-04-25 塞阔伊亚药品公司 抗耐药性反转录病毒蛋白酶抑制剂
MXPA06012909A (es) * 2004-05-07 2007-09-06 Sequoia Pharmaceuticals Inc Inhibidores de proteasa retroviral repelente de resistencia.
ES2331257T3 (es) 2005-02-25 2009-12-28 Tibotec Pharmaceuticals Sintesis de precursores de inhibidores de proteasas.
DE102010044584A1 (de) * 2010-09-07 2012-03-08 Kautex Textron Gmbh & Co. Kg Kraftstoffbehälter aus thermoplastischem Kunststoff
WO2014194519A1 (en) 2013-06-07 2014-12-11 Merck Sharp & Dohme Corp. Imidazole derivatives and methods of use thereof for improving pharmacokinetics of drug

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3021326A1 (de) 1980-06-06 1981-12-17 Drägerwerk AG, 2400 Lübeck Einrichtung zur messung von mindestens zwei pneumatischen lungenparametern und messverfahren hierzu
US4448192A (en) * 1982-03-05 1984-05-15 Hewlett Packard Company Medical ventilator device parametrically controlled for patient ventilation
IT1185906B (it) * 1985-09-13 1987-11-18 Luciano Gattinoni Sistema ed apparecchio biomedicale per la misurazione con precisione dei valori di variazione di pressione e volume nei polmoni di un paziente
US5136043A (en) * 1989-06-17 1992-08-04 Hoechst Aktiengesellschaft Process for the preparation of aromatic sulfonyl chlorides
DE3919840A1 (de) 1989-06-17 1991-01-17 Hoechst Ag Verfahren zur herstellung von aromatischen sulfonsaeurechloriden
DE69121436T2 (de) 1990-03-09 1997-01-09 Milliken Res Corp Organische Materialien, die sulfonamidogebundene Poly(oxyalkylen)gruppen tragen und ihre Herstellung
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
PH30929A (en) 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
IS2334B (is) 1992-09-08 2008-02-15 Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
AU7669794A (en) * 1993-08-24 1995-03-21 G.D. Searle & Co. Hydroxyethylamino sulphonamides useful as retroviral protease inhibitors
RU2170082C2 (ru) 1993-10-01 2001-07-10 Астра Актиеболаг Способ обработки лекарственного средства, устройство для формирования лекарственного средства и лекарственное средство
ES2173520T3 (es) 1993-11-23 2002-10-16 Searle & Co Metodo para elaborar productos intermedios utiles en la sintesis de inhibidores de proteasas retrovirales.
US6143747A (en) * 1995-01-20 2000-11-07 G. D. Searle & Co. Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
US5756533A (en) * 1995-03-10 1998-05-26 G.D. Searle & Co. Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
US6150556A (en) * 1995-03-10 2000-11-21 G. D. Dearle & Co. Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
ATE229033T1 (de) * 1995-03-10 2002-12-15 Searle & Co Heterocyclocarbonyl-aminosäure-hydroxyethylamin - sulfonamid inhibitoren retroviraler proteasen
US5705500A (en) 1995-03-10 1998-01-06 G.D. Searle & Co. Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
US5691372A (en) * 1995-04-19 1997-11-25 Vertex Pharmaceuticals Incorporated Oxygenated-Heterocycle containing sulfonamide inhibitors of aspartyl protease
US5753660A (en) * 1995-11-15 1998-05-19 G. D. Searle & Co. Substituted sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
GB9525994D0 (en) 1995-12-20 1996-02-21 Univ Manitoba Improvements in delivery of assist modes of mechanical ventilation
CA2240161C (en) 1996-05-20 2005-05-24 Janssen Pharmaceutica N.V. Antifungal compositions with improved bioavailability
IL129575A (en) 1997-03-26 2004-06-20 Janssen Pharmaceutica Nv Pills with a core coated with a fungicide and polymer
SE513969C2 (sv) * 1997-05-17 2000-12-04 Draegerwerk Ag Anordning och förfarande för bestämning av respirationssystemetsmekaniska egenskaper
WO1999006254A1 (de) * 1997-07-31 1999-02-11 Continental Teves Ag & Co. Ohg Verfahren und vorrichtung zur aktivierung einer bremsanlage
US6436989B1 (en) 1997-12-24 2002-08-20 Vertex Pharmaceuticals, Incorporated Prodrugs of aspartyl protease inhibitors
AU2012199A (en) 1997-12-24 1999-07-19 Vertex Pharmaceuticals Incorporated Prodrugs of aspartyl protease inhibitors
IL136940A0 (en) 1997-12-24 2001-06-14 Vertex Pharma Sulphonamide derivatives and pharmaceutical compositions containing the same
WO1999033792A2 (en) 1997-12-24 1999-07-08 Vertex Pharmaceuticals Incorporated Prodrugs os aspartyl protease inhibitors
WO1999067254A2 (en) * 1998-06-23 1999-12-29 The United States Of America Represented By The Secretary, Department Of Health And Human Services Multi-drug resistant retroviral protease inhibitors and use thereof
CA2336160C (en) 1998-06-23 2015-02-17 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Use of compounds for treating hiv
CZ300031B6 (cs) * 1999-10-06 2009-01-14 Tibotec Pharmaceuticals Ltd. Hexahydrofuro[2,3-b]furan-3-yl-N-{3-[(1,3-benzodioxol-5-ylsulfonyl) (isobutyl)amino]-1-benzyl-2-hydroxypropyl}karbamát a farmaceutický prípravek s jeho obsahem
OA12464A (en) * 2001-04-09 2006-05-24 Tibotec Pharm Ltd Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors.

Also Published As

Publication number Publication date
US20040132791A1 (en) 2004-07-08
SK13392003A3 (en) 2004-10-05
EP1397367A2 (en) 2004-03-17
MXPA03009179A (es) 2004-11-22
CN100491360C (zh) 2009-05-27
WO2002081478A3 (en) 2003-05-01
ZA200307683B (en) 2005-03-30
JP4417010B2 (ja) 2010-02-17
HRP20030905B1 (en) 2012-03-31
BG108218A (bg) 2004-09-30
IL158092A0 (en) 2004-03-28
AP1544A (en) 2006-01-12
US7244752B2 (en) 2007-07-17
PL367084A1 (en) 2005-02-21
NZ528954A (en) 2005-04-29
BG66371B1 (bg) 2013-10-31
HUP0303744A3 (en) 2008-03-28
NO20034505D0 (no) 2003-10-08
US20070135447A1 (en) 2007-06-14
CZ303139B6 (cs) 2012-04-25
HUP0303744A2 (hu) 2004-03-01
AU2002257774B2 (en) 2007-08-30
EE200300494A (et) 2003-12-15
EA200301110A1 (ru) 2004-04-29
NO20034505L (no) 2003-12-08
EA007383B1 (ru) 2006-10-27
KR100872029B1 (ko) 2008-12-05
AP2003002882A0 (en) 2003-12-31
HRP20030905A2 (en) 2005-08-31
BR0208796A (pt) 2004-03-09
CA2442870C (en) 2011-08-02
CA2442870A1 (en) 2002-10-17
EE05384B1 (et) 2011-02-15
WO2002081478A2 (en) 2002-10-17
CZ20032936A3 (cs) 2004-05-12
AR035819A1 (es) 2004-07-14
CN1636006A (zh) 2005-07-06
US7595334B2 (en) 2009-09-29
JP2004529144A (ja) 2004-09-24
SK288232B6 (sk) 2014-11-04
KR20030090719A (ko) 2003-11-28
NO328896B1 (no) 2010-06-07

Similar Documents

Publication Publication Date Title
US7595334B2 (en) Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors
AU2002302363B2 (en) Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide HIV protease inhibitors
IL166462A (en) Broadspectrum substituted oxindole sulfonamide hiv protease inhibitors
CA2444895C (en) Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors
AU2002310818A1 (en) Broadspectrum 2-amino-benzoxazole sulfonamide HIV protease inhibitors
AU2002257774A1 (en) Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors
AU2003238074B2 (en) Broadspectrum substituted benzisoxazole sulfonamide HIV protease inhibitors
IL163960A (en) Benzimidazoles Sulphonamides are broad-spectrum as vih protease inhibitors and as an overall preparation